CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer

COL-5671Positive
AI Analysis

Summary

Coultreon Biopharma appointed Dr. Prista Charuworn as Chief Medical Officer to accelerate clinical development of its first-in-class SIK3 inhibitor COL-5671.

Importance:2/10
Sentiment:
0.30
management changechief medical officerimmunologySIK3 inhibitorfirst-in-class
Related Companies

Read the original article

Published by GlobeNewswire Pharma on August 18, 2026 7:00 AM

Read Original